Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers

Authors

• M S. Brose

Publication/Presentation Date

10-2019

Volume

14

Issue

10

First Page

6

Last Page

7

Published In/Presented At

https://doi.org/10.1016/j.jtho.2019.08.059

Disciplines

Medicine and Health Sciences

Department(s)

Hematology-Medical Oncology Division

Document Type

Article